Corcept Therapeutics (CORT) has had the highest return since January 1, 2025 by a large-cap US stock, returning 125.6%.
| ASSET | % RETURN |
|---|---|
Corcept Therapeutics (CORT) | 125.64% |
Xpeng (XPEV) | 79.08% |
Gold Fields Ltd ADR (GFI) | 63.22% |
AngloGold Ashanti (AU) | 59.89% |
Intracellular Th (ITCI) | 56.75% |
Alibaba (BABA) | 56.69% |
CVS Health (CVS) | 52.1% |
Banco Santander SA ADR (SAN) | 49.89% |
BeiGene (ONC) | 49.13% |
Elbit Systems (ESLT) | 46.12% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 44.13% |
Alamos Gold (AGI) | 42.99% |
Lloyds Banking Group PLC ADR (LYG) | 41.48% |
Bancolombia SA ADR (CIB) | 39.08% |
Deutsche Bank (DB) | 38.55% |
Prudential PLC ADR (PUK) | 37.52% |
Agnico Eagle Mines (AEM) | 37.11% |
Wheaton Precious Metals (WPM) | 35.6% |
Kinross Gold (KGC) | 34.43% |
Franco-Nevada (FNV) | 32.58% |
Itau Unibanco Banco (ITUB) | 32.37% |
Philip Morris International (PM) | 31.97% |
Okta (OKTA) | 31.53% |
Ecopetrol SA ADR (EC) | 30.5% |
Futu (FUTU) | 30.08% |
Large-cap stocks are treated as having a market cap of $10B+.
